Effects of early intravenous low-dose of metoprolol on cardiac sympathetic activities and electrophysiological properties in myocardial infarction heart

被引:4
作者
Wang, Dan-Ning [1 ]
Wang, Lei [1 ]
Huang, Ying [1 ]
Hua, Li [1 ]
Cui, Hai-Ming [1 ]
Chen, Peng-Fei [2 ]
Liang, Xin [1 ]
Zhang, Jia-You [1 ]
Liao, De-Ning [1 ]
机构
[1] Shanghai Changzheng Hosp, Dept Cardiol, 415 Fengyang Rd, Shanghai 200433, Peoples R China
[2] Chinese Peoples Liberat Army, Hosp 309, Dept Cardiol, Beijing 100193, Peoples R China
基金
中国国家自然科学基金;
关键词
metoprolol; beta-blocker; myocardial infarction; effective refractory period; BETA-BLOCKER; RISK-FACTORS; DISEASE;
D O I
10.3892/etm.2018.6695
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study observed the effects of early intravenous low-doses of metoprolol on cardiac sympathetic activities and electrophysiological properties in myocardial infarction (MI) dogs. Thirty two mongrel dogs with the first diagonal branch of the left anterior descending coronary artery ligated were randomly divided into three groups: The low-dose group was given metoprolol 0.6 mg/kg immediately by intravenous injection (n=12); the target-dose group was given metoprolol 1.6 mg/kg (n=12), and the control group was injected with normal saline at the same dose of the target-dose group (n=8). Norepinephrine (NE) and epinephrine (E) levels in the coronary sinus (CS) blood as well as the ventricular effective refractory period (ERP) were all measured during the experiments. We found that NE and E concentrations in the three groups were all increased compared with the previous measurement before ligation. ERP values after MI were significantly decreased in all three groups compared with the first measurements. The three groups all exhibited uneven shortness of ERP among different regions, with significant shortness in infarcted area. Furthermore, there was no difference between the low and target-dose of metoprolol in the reduction of regional ERP, and the same effect was also observed in induced arrhythmias. In conclusion, a lower dose of metoprolol performed similarly as target-dose in reducing the catecholamine concentrations in dogs with MI. Our study demonstrated that a lower dose of metoprolol may be reasonable compared with the target-dose in beta-blocker therapy due to similar effect and lower toxicity.
引用
收藏
页码:4114 / 4118
页数:5
相关论文
共 25 条
[1]   Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study [J].
Assmann, G ;
Cullen, P ;
Schulte, H .
CIRCULATION, 2002, 105 (03) :310-315
[2]   After myocardial infarction carvedilol improves insulin resistance compared to metoprolol [J].
Basat O. ;
Ucak S. ;
Seber S. ;
Oztekin E. ;
Altuntas Y. .
Clinical Research in Cardiology, 2006, 95 (2) :99-104
[3]   Inadequate medical treatment of patients with coronary artery disease by primary care physicians in Germany [J].
Bischoff, B. ;
Silber, S. ;
Richartz, B. M. ;
Pieper, L. ;
Klotsche, J. ;
Wittchen, H. -U. .
CLINICAL RESEARCH IN CARDIOLOGY, 2006, 95 (08) :405-412
[4]   Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis [J].
Bolland, Mark J. ;
Avenell, Alison ;
Baron, John A. ;
Grey, Andrew ;
MacLennan, Graeme S. ;
Gamble, Greg D. ;
Reid, Ian R. .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 :289
[5]   Quercetin alleviates cell apoptosis and inflammation via the ER stress pathway in vascular endothelial cells cultured in high concentrations of glucosamine [J].
Cai, Xiaxia ;
Bao, Lei ;
Ding, Ye ;
Dai, Xiaoqian ;
Zhang, Zhaofeng ;
Li, Yong .
MOLECULAR MEDICINE REPORTS, 2017, 15 (02) :825-832
[6]   Number of Coronary Heart Disease Risk Factors and Mortality in Patients With First Myocardial Infarction [J].
Canto, John G. ;
Kiefe, Catarina I. ;
Rogers, William J. ;
Peterson, Eric D. ;
Frederick, Paul D. ;
French, William J. ;
Gibson, C. Michael ;
Pollack, Charles V., Jr. ;
Ornato, Joseph P. ;
Zalenski, Robert J. ;
Penney, Jan ;
Tiefenbrunn, Alan J. ;
Greenland, Philip .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (19) :2120-2127
[7]  
Costalunga A, 2001, Ital Heart J Suppl, V2, P1246
[8]  
DAWBER T. R., 1957, AMER JOUR PUBL HEALTH, V47, P4, DOI 10.2105/AJPH.47.4_Pt_2.4
[9]   Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction [J].
Gislason, GH ;
Rasmussen, JN ;
Abildstrom, SZ ;
Gadsboll, N ;
Buch, P ;
Friberg, J ;
Rasmussen, S ;
Kober, L ;
Stender, S ;
Madsen, M ;
Torp-Pedersen, C .
EUROPEAN HEART JOURNAL, 2006, 27 (10) :1153-1158
[10]  
Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80